Rosiglitazone and cardiotoxicity - Weighing the evidence

被引:80
作者
Nathan, David M. [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
关键词
D O I
10.1056/NEJMe078117
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:64 / 66
页数:3
相关论文
共 10 条
[1]   Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes [J].
Choi, D ;
Kim, SK ;
Choi, SH ;
Ko, YG ;
Ahn, CW ;
Jang, YS ;
Lim, SK ;
Lee, HC ;
Cha, BS .
DIABETES CARE, 2004, 27 (11) :2654-2660
[2]   Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].
Dormandy, JA ;
Charbonnel, B ;
Eckland, DJA ;
Erdmann, E ;
Massi-Benedetti, M ;
Kmoules, IK ;
Skene, AM ;
Tan, MH ;
Lefébvre, PJ ;
Murray, GD ;
Standl, E ;
Wilcox, RG ;
Wlhelmsen, L ;
Betteridge, J ;
Birkeland, K ;
Golay, A ;
Heine, RJ ;
Korányi, L ;
Laakso, M ;
Mokán, M ;
Norkus, A ;
Pirags, V ;
Podar, T ;
Scheen, A ;
Scherbaum, W ;
Schernthaner, G ;
Schmitz, O ;
Skrha, J ;
Smith, U ;
Taton, J .
LANCET, 2005, 366 (9493) :1279-1289
[3]   Rosiglitazone RECORD study: glucose control outcomes at 18 months [J].
Home, P. D. ;
Jones, N. P. ;
Pocock, S. J. ;
Beck-Nielsen, H. ;
Gomis, R. ;
Hanefeld, M. ;
Komajda, M. .
DIABETIC MEDICINE, 2007, 24 (06) :626-634
[4]   Rosiglitazone evaluated for cardiac outcomes and regulation of glycaemia in diabetes (RECORD): Study design and protocol [J].
Home, PD ;
Pocock, SJ ;
Beck-Nielsen, H ;
Gomis, R ;
Hanefeld, M ;
Dargie, H ;
Komajda, M ;
Gubb, J ;
Biswas, N ;
Jones, NP .
DIABETOLOGIA, 2005, 48 (09) :1726-1735
[5]   Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].
Home, Philip D. ;
Pocock, Stuart J. ;
Beck-Nielsen, Henning ;
Gomis, Ramon ;
Hanefeld, Markolf ;
Jones, Nigel P. ;
Komajda, Michel ;
McMurray, John J. V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38
[6]   Finding new treatments for diabetes - How many, how fast ... How good? [J].
Nathan, David M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (05) :437-440
[7]   Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes (vol 356, pg 2457, 2007) [J].
Nissen, Steven E. ;
Wolski, Kathy .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2457-2471
[8]   Rosiglitazone and cardiovascular risk [J].
Psaty, Bruce M. ;
Furberg, Curt D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24) :2522-2524
[9]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[10]   Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [J].
Turner, RC ;
Holman, RR ;
Stratton, IM ;
Cull, CA ;
Matthews, DR ;
Manley, SE ;
Frighi, V ;
Wright, D ;
Neil, A ;
Kohner, E ;
McElroy, H ;
Fox, C ;
Hadden, D .
LANCET, 1998, 352 (9131) :854-865